Report Presentation Webcast
October 21, 2021 Interview Erik Penser Bank
September 29, 2021 Naventus LifeScience Summit
September 7, 2021 Presentation at Aktiedagen Stockholm
August 19, 2021 Interim Report January – June 2021
June 11, 2021 Aktiespararna: Interview with Oasmia Pharmaceutical
May 27, 2021 Interim Report January – March 2021
April 29, 2021 Annual Report 2020
April 12, 2021 Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting
March 21, 2021 BioEurope Spring, Virtual
March 11, 2021 Sachs 14th Annual European Life Sciences CEO Forum, Virtual
March 1, 2021 Oasmia acquires global development and commercialization rights for Cantrixil
February 19, 2021 Year-end report 2020
February 10, 2021 Swiss Nordic Bio
January 19, 2021 SEB Digital Healthcare Seminar Presentation